Placebo response in binge eating disorder: A pooled analysis of 10 clinical trials from one research group

European Eating Disorders Review

Volumn 22, Issue 2, 2014, Pages 140-146

  Blom, Thomas J ^a,b   Mingione, Carolyn J ^b,c   Guerdjikova, Anna I ^a   Keck, Paul E ^a   Welge, Jeffrey A ^a   McElroy, Susan L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b LINDNER CENTER OF HOPE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

binge eating disorder; clinical; placebo response; pooled analysis; trial

Indexed keywords

ACAMPROSATE; ATOMOXETINE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; LAMOTRIGINE; PLACEBO; SERTRALINE; TOPIRAMATE; ZONISAMIDE;

ADULT; ARTICLE; BINGE EATING DISORDER; BODY MASS; CLINICAL GLOBAL IMPRESSION SCALE; DOUBLE BLIND PROCEDURE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PLACEBO EFFECT; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; THREE-FACTOR-EATING-QUESTIONNAIRE; TREATMENT RESPONSE; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

BINGE EATING DISORDER; CLINICAL; PLACEBO RESPONSE; POOLED ANALYSIS; TRIAL;

ADULT; BINGE-EATING DISORDER; BODY MASS INDEX; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84896717828     PISSN: 10724133     EISSN: 10990968     Source Type: Journal    
DOI: 10.1002/erv.2277     Document Type: Article

References (40)

1. Akaike, H., (1974). A new look at the statistical model identification. IEEE Transactions on Automatic Control, 19 (6), 716-723.
2. Arnold, L. M., McElroy, S. L., Hudson, J. I., Welge, J. A., Bennett, A. J., &, Keck, P. E., (2002). A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. Journal of Clinical Psychiatry, 63 (11), 1028-1033.
3. Bacaltchuk, J., &, Hay, P., (2003). Antidepressants versus placebo for people with bulimia nervosa. Cochrane Database of Systematic Reviews, (4), CD003391.
4. Burnham, K. P., &, Anderson, D. R., (1998). Model selection and inference: A practical information-theoretic approach. New York, NY: Springer-Verlag.
5. Carter, W. P., Hudson, J. I., Lalonde, J. K., Pindyck, L., McElroy, S. L., &, Pope, H. G., Jr., (2003). Pharmacologic treatment of binge eating disorder. International Journal of Eating Disorders, 34 Suppl, S74-88.
6. Cepeda, M. S., Berlin, J. A., Gao, C. Y., Wiegand, F., &, Wada, D. R., (2012). Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis. Pain Medicine, 13 (4), 575-595.
7. Charney, D. S., Nemeroff, C. B., Lewis, L., Laden, S. K., Gorman, J. M., Laska, E. M., et al. (2002). National depressive and manic-depressive association consensus statement on the use of placebo in clinical trials of mood disorders. Archives of General Psychiatry, 59 (3), 262-270.
8. Diederich, N. J., &, Goetz, C. G., (2008). The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies. Neurology, 71 (9), 677-684.
9. First, M. B., Spitzer, R. L., Gibbon, M., &, Williams, J. B. W., (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition with Psychotic Screen (SCID-I/P W/PSY SCREEN). New York, NY: Biometric Research; New York State Psychiatric Institute.
10. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., et al. (1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry, 46 (11), 1006-1011.
11. Guerdjikova, A. I., McElroy, S. L., Kotwal, R., Welge, J. A., Nelson, E., Lake, K., et al. (2008). High-dose escitalopram in the treatment of binge-eating disorder with obesity: A placebo-controlled monotherapy trial. Human Psychopharmacology, 23 (1), 1-11.
12. Guerdjikova, A. I., McElroy, S. L., Welge, J. A., Nelson, E., Keck, P. E., &, Hudson, J. I., (2009). Lamotrigine in the treatment of binge-eating disorder with obesity: A randomized, placebo-controlled monotherapy trial. International Clinical Psychopharmacology, 24 (3), 150-158.
13. Guerdjikova, A. I., McElroy, S. L., Winstanley, E. L., Nelson, E. B., Mori, N., McCoy, J., et al. (2012). Duloxetine in the treatment of binge eating disorder with depressive disorders: A placebo-controlled trial. International Journal of Eating Disorders, 45, 281-289.
14. Guy, W., (1976). Clinical Global Improvement Scale. In ECDEU Assessment Manual for Psychopharmacology-Revised (DHEW Publ No ADM 76-338). Rockville, MD: U.S. Department of Health, Education, and Welfare pp. 218-222.
15. Hamilton, M., (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56-62.
16. Hudson, J. I., Hiripi, E., Pope, H. G., Jr., &, Kessler, R. C., (2007). The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 61 (3), 348-358.
17. Hurvich, C. M., &, Tsai, C. L., (1989). Regression and time series model selection in small samples. Biometrika, 76, 297-307.
18. Iovieno, N., &, Papakostas, G. I., (2012). Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: A meta-analysis. Journal of Clinical Psychiatry, 73 (10), 1300-1306.
19. Jacobs-Pilipski, M. J., Wilfley, D. E., Crow, S. J., Walsh, B. T., Lilenfeld, L. R., West, D. S., et al. (2007). Placebo response in binge eating disorder. International Journal of Eating Disorders, 40 (3), 204-211.
20. Kessler, R. C., Berglund, P. A., Chiu, W. T., Deitz, A. C., Hudson, J. I., Shahly, V., et al. (2013). The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health surveys. Biological Psychiatry, 73 (9), 904-914.
21. Khan, A., Brodhead, A. E., Kolts, R. L., &, Brown, W. A., (2005). Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials. J Psychiat Res, 39, 145-150.
22. Khan, A., Leventhal, R. M., Khan, S. R., &, Brown, W. A., (2002). Severity of depression and response to antidepressants and placebo: An analysis of the food and drug administration database. Journal of Clinical Psychopharmacology, 22 (1), 40-45.
23. Khin, N. A., Chen, Y. F., Yang, Y., Yang, P., &, Laughren, T. P., (2011). Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications. Journal of Clinical Psychiatry, 72 (4), 464-472.
24. Klosterhalfen, S., &, Enck, P., (2008). Neurophysiology and psychobiology of the placebo response. Current Opinion in Psychiatry, 21 (2), 189-195.
25. Mallinckrodt, C. H., Tamura, R. N., &, Tanaka, Y., (2011). Recent developments in improving signal detection and reducing placebo response in psychiatric clinical trials. Journal of Psychiatric Research, 45 (9), 1202-1207.
26. McElroy, S. L., Arnold, L. M., Shapira, N. A., Keck, P. E., Jr., Rosenthal, N. R., Karim, M. R., et al. (2003). Topiramate in the treatment of binge eating disorder associated with obesity: A randomized, placebo-controlled trial. The American Journal of Psychiatry, 160 (2), 255-261.
27. McElroy, S. L., Casuto, L. S., Nelson, E. B., Lake, K. A., Soutullo, C. A., Keck, P. E., Jr., et al. (2000). Placebo-controlled trial of sertraline in the treatment of binge eating disorder. The American Journal of Psychiatry, 157 (6), 1004-1006.
28. McElroy, S. L., Guerdjikova, A., Kotwal, R., Welge, J. A., Nelson, E. B., Lake, K. A., et al. (2007). Atomoxetine in the treatment of binge-eating disorder: A randomized placebo-controlled trial. Journal of Clinical Psychiatry, 68 (3), 390-398.
29. McElroy, S. L., Guerdjikova, A. I., Mori, N., &, O'Melia, A. M., (2012). Pharmacolgical management of binge eating disorder: Current and emerging treatment options. Therapeutics and Clinical Risk Management, 8, 219-241.
30. McElroy, S. L., Guerdjikova, A. I., Winstanley, E. L., O'Melia, A. M., Mori, N., McCoy, J., et al. (2011). Acamprosate in the treatment of binge eating disorder: A placebo-controlled trial. International Journal of Eating Disorders, 44 (1), 81-90.
31. McElroy, S. L., Hudson, J. I., Malhotra, S., Welge, J. A., Nelson, E. B., &, Keck, P. E., Jr., (2003). Citalopram in the treatment of binge-eating disorder: A placebo-controlled trial. Journal of Clinical Psychiatry, 64 (7), 807-813.
32. McElroy, S. L., Kotwal, R., Guerdjikova, A. I., Welge, J. A., Nelson, E. B., Lake, K. A., et al. (2006). Zonisamide in the treatment of binge eating disorder with obesity: A randomized controlled trial. Journal of Clinical Psychiatry, 67 (12), 1897-1906.
33. Reas, D. L., &, Grilo, C. M., (2008). Review and meta-analysis of pharmacotherapy for binge-eating disorder. Obesity (Silver Spring), 16 (9), 2024-2038.
34. Stefano, S. C., Bacaltchuk, J., Blay, S. L., &, Appolinario, J. C., (2008). Antidepressants in short-term treatment of binge eating disorder: systematic review and meta-analysis. Eating Behaviors, 9 (2), 129-136.
35. Striegel-Moore, R. H., &, Franko, D. L., (2003). Epidemiology of binge eating disorder. International Journal of Eating Disorders, 34 Suppl, S19-29.
36. Stunkard, A. J., &, Messick, S., (1988). Eating Inventory Manual. San Antonio, TX: Pearson.
37. Sysko, R., &, Walsh, B. T., (2007). A systematic review of placebo response in studies of bipolar mania. Journal of Clinical Psychiatry, 68 (8), 1213-1217.
38. Walsh, B. T., &, Boudreae, G., (2003). Laboratory studies of binge eating disorder. International Journal of Eating Disorders, 34, S30-38.
39. Walsh, B. T., Seidman, S. N., Sysko, R., &, Gould, M., (2002). Placebo response in studies of major depression: Variable, substantial, and growing. JAMA, 287 (14), 1840-1847.
40. Wonderlich, S. A., Gordon, K. H., Mitchell, J. E., Crosby, R. D., &, Engel, S. G., (2009). The validity and clinical utility of binge eating disorder. International Journal of Eating Disorders, 42 (8), 687-705.